SURVEY SUPPLIES LIMITED
Company number 00965862 · Monitor this company
This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.
Financial Health Assessment: Survey Supplies Limited
1. Financial Health Score: B-
Explanation: Survey Supplies Limited presents a fundamentally sound constitution but is exhibiting concerning symptoms of financial strain. The company maintains a strong asset base and healthy equity position, but the dramatic decline in operating profitability and significant cash depletion warrant close monitoring. Like a patient with a robust frame but developing circulatory issues, the underlying structure is healthy, but the flow of financial nutrients is becoming constrained.
2. Key Vital Signs
| Vital Sign | 2024 | 2023 | 2022 | Interpretation |
|---|---|---|---|---|
| Net Assets | £9,610,940 | £9,291,133 | £8,510,020 | ✅ Healthy and growing – up 12.9% over two years |
| Cash Position | £548,140 | £1,615,664 | £1,591,683 | ⚠️ Alarming decline – 66% drop in one year |
| Total Assets | £15,205,177 | £13,649,862 | £12,555,220 | ✅ Growing asset base – up 21% over two years |
| Total Liabilities | £7,904,915 | £6,533,613 | £6,016,171 | ⚠️ Rising debt – up 31% over two years |
| Operating Profit | £739,127 | £1,397,636 | - | 🔴 Critical decline – 47% drop year-on-year |
| Gross Margin | 33.0% | 33.2% | - | ✅ Stable – competitive positioning maintained |
| Debt-to-Equity Ratio | 0.82:1 | 0.70:1 | 0.71:1 | ⚠️ Increasing leverage – trending upward |
| Cash/Total Assets | 3.6% | 11.8% | 12.7% | 🔴 Critically low liquidity ratio |
3. Diagnosis
What the Financial Data Reveals About Business Health
🫀 The Heart – Cash Flow Health: WEAKENED The most alarming symptom is the 66% decline in cash reserves, dropping from £1.6 million to £548,140. This represents a severe constriction in the company's financial circulation. While part of this decline is attributable to the £1.8 million investment in the hire fleet (a strategic capital expenditure), the resulting cash position leaves limited reserves for operational flexibility. With only 3.6% of total assets held as cash, the company has minimal liquidity buffer against unexpected demands.
🧬 The DNA – Asset Structure: CHANGING Total assets grew by £1.56 million (11.4%), primarily driven by the hire fleet investment. This shift in asset composition—from liquid current assets to fixed assets—represents a strategic transformation in the business model. The company is effectively converting readily-available financial resources into long-term revenue-generating equipment. This is not inherently unhealthy, but it does make the business more dependent on that equipment performing and generating hire income.
🫁 The Lungs – Profitability: COMPROMISED The 47% decline in operating profit is the most critical symptom requiring diagnosis. Despite turnover remaining broadly flat (only a 2.8% decline), profitability has nearly halved. This indicates that the company's cost structure has expanded significantly faster than its revenue. The directors acknowledge this in their strategic report, noting they "continue to invest in staff and facilities" while "re-aligning overhead structure." This suggests the company is in a transitional investment phase, but the timeline for return on this investment remains uncertain.
🦴 The Skeleton – Equity Foundation: STRONG Net assets grew by £319,807 (3.4%) to £9.61 million, demonstrating that the fundamental equity structure remains robust. Shareholders' funds consistently equal net assets, indicating no accumulated preference dividends or other equity complications. The debt-to-equity ratio, while rising, remains below 1:1, indicating the company is not over-leveraged.
💉 The Blood Transfusion – Dividend Policy: QUESTIONABLE The company declared dividends of £525,250 in both 2023 and 2024. While maintaining shareholder returns is important, continuing to extract over half a million pounds when operating profit has fallen by 47% and cash reserves are depleted raises concerns about financial stewardship. The 2024 dividend represents 71% of operating profit, compared to just 38% in 2023. This high payout ratio during a profit downturn could further compromise the company's ability to rebuild its cash reserves.
4. Prognosis
Future Financial Outlook: CAUTIOUSLY OPTIMISTIC WITH CONDITIONS
Positive Prognostic Indicators: - The company has over 55 years of trading history, suggesting resilience and adaptability - Gross margins remain stable at 33%, indicating competitive positioning is intact - The £1.8 million hire fleet investment should generate future rental income - The auditor has confirmed the going concern basis with no material uncertainties - Net assets continue to grow, providing a substantial equity cushion - The relationship with Trimble (a major technology partner) remains supportive
Negative Prognostic Indicators: - If overhead growth continues without corresponding revenue increases, profitability will further erode - The low cash position leaves limited room for unexpected challenges or opportunities - The cyclical nature of the construction sector (acknowledged as a principal risk) could amplify current vulnerabilities - Continued high dividend extraction during a downturn could delay financial recovery
Overall Outlook: The company is experiencing a period of investment and margin compression, but is not in financial distress. Recovery depends on the hire fleet investment generating incremental revenue and management successfully realigning the overhead structure. The construction sector cycle remains a significant external risk factor.
5. Recommendations
Immediate Actions (Within 3 Months)
-
🩹 Cash Flow Triage: Conduct an immediate cash flow forecast and stress test. With only £548K in reserves, establish minimum cash thresholds and monitor weekly. Consider renegotiating payment terms with key customers to accelerate inflows.
-
💊 Dividend Review: Suspend or significantly reduce the dividend until operating profit recovers and cash reserves are rebuilt to at least £1 million. The current 71% payout ratio on declining profits is unsustainable and risks financial health.
-
🔬 Overhead Surgery: Accelerate the overhead realignment mentioned in the strategic report. Identify specific cost reduction targets with timelines. Every month of inflated overheads bleeds the company's financial reserves.
Medium-Term Actions (3-12 Months)
-
💪 Hire Fleet Revenue Generation: Develop a detailed business case for the £1.8 million hire fleet investment, including projected utilization rates, revenue targets, and payback period. Monitor actual performance against these targets monthly.
-
🩺 Working Capital Optimization: Review inventory levels, debtor days, and creditor terms. With cash constrained, maximizing working capital efficiency is essential. Target a reduction in debtor days and consider invoice finance facilities (noting Close Invoice Finance is already a banker).
-
📊 Key Performance Indicator Expansion: While gross margin is monitored, add operating margin, cash conversion cycle, and return on capital employed as board-level KPIs. What gets measured gets managed.
Long-Term Strategic Considerations
-
🏥 Sector Diversification Health Check: The strategic report mentions operating "across all sectors of the industry" to mitigate cyclical risk. Verify this diversification is genuinely balanced and not over-concentrated in any single sub-sector that may be particularly vulnerable.
-
🧬 Capital Structure Review: With rising liabilities and declining cash, review the optimal capital structure. Consider whether some of the hire fleet investment should be financed through asset finance rather than cash, preserving liquidity.
Risk Assessment Summary
| Risk Category | Level | Key Concern |
|---|---|---|
| Liquidity Risk | 🔴 HIGH | Cash reserves critically low |
| Profitability Risk | 🟡 MEDIUM | Significant profit decline but margins stable |
| Leverage Risk | 🟡 MEDIUM | Debt rising but equity cushion strong |
| Operational Risk | 🟢 LOW | Well-established business with strong market position |
| Going Concern Risk | 🟢 LOW | Auditor confirmed no material uncertainties |